Of interest, the SH3 domain-binding glutamate-rich protein-like (SH3BGRL), a scaffold protein expressed in various human tissues, is downregulated in AML and enhances drug sensitivity in AML patients [15]. The gene discussed is SH3BGRL; the disease is acute myeloid leukemia.